Tweed Inc., a wholly-owned subsidiary of Canopy Growth Corporation (TSX:WEED) today announced that it has completed an intensive process of sourcing a diverse genetic seed bank and legally importing it into Canada. Tweed will begin selling cannabis seeds to authorized home growers under the Access to Cannabis for Medical Purposes Regulations in early March.
Tweed has long supported patients’ right to grow their own cannabis and is proud to be able to support those who would prefer to grow their own medical supply. Tweed is only the second producer in Canada to offer a seed option and will also offer a wide variety of dried cannabis and cannabis oil products to authorized grow at home customers as a reliable interim supply during the months it takes home growers to produce their medicine. The Company will also offer seed customers will a one-time $25 discount that can be used towards the purchase of any Tweed cannabis product.
Kevin Furet, Tweed’s Master Grower and an award-winning breeder in his own right, curated a collection of genetics with lineages originating all around the world. The resulting Tweed HomeGrow Collection is made up of ten seed types designed to meet the diverse needs of patients.
“I was aiming for quality and diversity in this collection,” said Furet. “Medical cannabis patients have diverse needs so I wanted to create a collection that matched that diversity. I see ten options as a starting point that we can build on using our own cross breeding capabilities in our custom breeding area.”
The same seeds used in the HomeGrow collection will be grown out in Tweed’s breeding facility to produce proprietary genetics that can be sold as seed or as finished products. Announced late last year, the breeding area is a first in Canada and will allow Tweed to crossbreed existing genetics for all registered customers, including home growers.
Health Canada provides authorization for home production licenses. Interested individuals can visit the Health Canada website for more information on obtaining an authorization.
Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) announces it has completed a first closing of a non-brokered private placement of up to $2,000,000. The Company accepted subscriptions for 13,740,000 units at a price of $0.05 per unit, for gross proceeds of $687,000. Each unit consists of one common share and one common share purchase warrant. Each warrant entitles the holder to purchase one additional common share at $0.075 for a period of two years from the date of closing, subject to the option of the Company to accelerate the expiry date in the event that its shares trade at $0.15 or more for 10 consecutive days
The Company paid $18,000 in cash and issued 160,000 warrants on the same terms as noted above to qualified finders. Securities issued pursuant to this tranche are subject to trading restrictions until April 5, 2021. The Company is expecting to complete the financing by December 16, 2020. Proceeds will be used for working capital and to fund future investments.
Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”), announces that further to its press release dated December 3, 2020, the TSX Venture Exchange has approved the repricing of 19,405,804 warrants of the Company that were originally issued on July 27, 2018, to $0.10. These warrants are set to expire on December 31, 2020.
For anybody wishing to exercise these Warrants, please contact the Chief Executive Officer, Terry Donnelly at the particulars below.
Cannabis Profits In Focus: CEO’s of HEXO, Icanic Brands, Tilray, and Aurora Cannabis Discuss Next Wave of Global Growth Opportunities and Brands Innovation
Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN), Aurora Cannabis (NYSE: ACB) (TSX: ACB), and HEXO Corp. (NYSE: HEXO)
Cannabis leaders are focusing on innovation in premium branding, global expansion, and tight operational execution in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders:
TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce that it has closed the 2nd and final tranche of its Unit financing. In connection with the closing, the Company issued 1,356,873 Units at a price of $0.55 per Unit, for gross proceeds of $746,280.15. Each Unit consists of one (1) common share and one (1) warrant. Each warrant entitles the holder to purchase one common share of the Company, at an exercise price of $0.75 per share, for a period of two years from the date of issuance. The warrants are subject to an acceleration right that allows the Company to give notice of an earlier expiry date if the Company’s share price on the CSE (or such other stock exchange the Company’s shares may be trading on) is equal to or greater than $1.25 for a period of 20 consecutive trading days. Finder’s fees of $42,542, 3,200 Finder’s shares and 80,550 Finder’s warrants were issued in connection with finder’s fees payable.
In total, the Company raised gross proceeds of $1,757,180 and issued 3,194,873 Units.
Sweet Earth Holdings Corp. (CSE: SE) (FSE: 1KZ1) (OTCQB: SEHCF) (“Sweet Earth” the “Company”) is pleased to announce that it has received full Depository Trust Company (“DTC”) eligibility in the United States. On October 20, 2020, Sweet Earth announced that its shares had been listed on the United States’ Over-The-Counter Bulletin (“OTCQB”) under the ticker SEHCF.
DTC status means that Sweet Earth shares are now eligible to be transferred between brokerage accounts within the United States and significantly augments the ease in which American-based investors are able to trade Sweet Earth shares.